[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2021-005589-16"
            }
        ],
        "amendment_date": null,
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "Arcus Biosciences, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Male or female participants \u2265 18 years of age (or age \u2265 regionally approved age of consent for participation in investigational clinical studies) at the time of signing the informed consent."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Contraceptive use by men and women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Adequate organ and marrow function"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 5,
                    "description": "History of trauma or major surgery within 28 days prior to the first dose of study treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 6,
                    "description": "Prior treatment with an anti-TIGIT antibody."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 7,
                    "description": "Any active or prior autoimmune disease that required treatment within 3 years of the first dose of study treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 8,
                    "description": "Prior chemotherapy, targeted small-molecule therapy, immunotherapy, or biologic agents, or use of other investigational drugs within 28 days before first dose of study treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 9,
                    "description": "Discontinued prior immunotherapy for immune related adverse events with a high severity."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB308 in Combination With AB122 in Participants With Advanced Malignancies",
        "_phase_sort_order": 4,
        "collaborators": [
            {
                "name": "Gilead",
                "functional_role": "LABORATORY"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "From the date of first occurrence of a documented objective response to first documentation of disease progression or death from any cause, whichever occurs first (up to approximately 3-5 years)",
                "name": "Duration of Response",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From first study treatment administration through Day 21 (Q3W arm) or Day 28 (Q4W arm) or Day 42 (Q6W arm)",
                "name": "Percentage of participants who experience a Dose Limiting Toxicity",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From first study treatment administration until up to 90 days after the last dose (Approximately 1 year)",
                "name": "Percentage of participants with Adverse Events",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Recorded at baseline (day 1 of cycle 1), during each of the first 5 cycles (each cycle is 21 days or 28 days or 42 days) and up to the first 16 cycles of treatment (up to 22 months), and 30 and 90 days post last dose (up to approximately 25 months)",
                "name": "Percentage of participants with anti-drug antibodies to AB308",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Recorded at baseline (day 1 of cycle 1), during each of the first 5 cycles (each cycle is 21 days or 28 days or 42 days) and up to the first 16 cycles of treatment (up to 22 months), and 30 and 90 days post last dose (up to approximately 25 months)",
                "name": "Percentage of participants with anti-drug antibodies to zimberelimab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From study enrollment until disease progression or loss of clinical benefit (up to approximately 3-5 years)",
                "name": "Percentage of Participants with Disease Control (complete response, partial response, or stable disease) for >6 months",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From study enrollment until participant discontinuation, first occurrence of progressive disease, or death from any cause, whichever occurs first (up to approximately 3-5 years)",
                "name": "Percentage of participants with Objective Response",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Recorded at baseline (day 1 of cycle 1), during each of the first 5 cycles (each cycle is 21 days or 28 days or 42 days) and up to the first 16 cycles of treatment (up to 22 months), and 30 and 90 days post last dose (up to approximately 25 months)",
                "name": "Serum concentration of AB308",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Recorded at baseline (day 1 of cycle 1), during each of the first 5 cycles (each cycle is 21 days or 28 days or 42 days) and up to the first 16 cycles of treatment (up to 22 months), and 30 and 90 days post last dose (up to approximately 25 months)",
                "name": "Serum concentration of zimberelimab",
                "description": null,
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 8,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04772989",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "CD274",
                    "CD274 Molecule Gene",
                    "PD-L1",
                    "PDL1"
                ],
                "nci_thesaurus_concept_id": "C96022",
                "name": "CD274 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612"
                ],
                "parents": [
                    "C20103"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Histopathologic Result",
                    "Microscopic Finding"
                ],
                "nci_thesaurus_concept_id": "C83490",
                "name": "Histopathology Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C125581",
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C125581"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "B7 Homolog 1 Positive",
                    "B7-H Positive",
                    "B7H1 Positive",
                    "CD274 Antigen Positive",
                    "CD274 Molecule Positive",
                    "CD274 Positive",
                    "Expression of PD-L1",
                    "PD-L1+",
                    "PDCD1L1 Positive",
                    "PDCD1LG1 Positive",
                    "PDL1 Positive",
                    "Positive",
                    "Programmed Cell Death 1 Ligand 1 Positive"
                ],
                "nci_thesaurus_concept_id": "C128554",
                "name": "PD-L1 Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C40998",
                    "C3367",
                    "C77140",
                    "C20103",
                    "C125581",
                    "C16612",
                    "C122807",
                    "C83490",
                    "C177692",
                    "C21295",
                    "C96022",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C122807",
                    "C177692",
                    "C96022"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Immunophenotypic Test Result"
                ],
                "nci_thesaurus_concept_id": "C40998",
                "name": "Immunophenotypic Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C125581",
                    "C83490",
                    "C36292"
                ],
                "parents": [
                    "C83490"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "CD274 Immunohistochemistry",
                    "CD274 Status by Immunohistochemistry",
                    "Immunohistochemical Status of CD274",
                    "PD-L1 IHC Status",
                    "PD-L1 Immunohistochemistry",
                    "PD-L1 Immunohistochemistry Status",
                    "PD-L1 Status by Immunohistochemistry"
                ],
                "nci_thesaurus_concept_id": "C122807",
                "name": "Immunohistochemical Status of PD-L1",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C125581",
                    "C16612",
                    "C21295",
                    "C83490",
                    "C96022",
                    "C40998",
                    "C36292"
                ],
                "parents": [
                    "C40998",
                    "C96022"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Pathologic Examination Result",
                    "Pathologic Result"
                ],
                "nci_thesaurus_concept_id": "C125581",
                "name": "Pathology Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2021-03-19",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Solid Tumor",
                    "Advanced Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Hematologic Cancer",
                    "Hematopoietic Cancer",
                    "Hematological Neoplasm",
                    "Hematopoietic Neoplasm",
                    "Malignant Hematologic Neoplasm",
                    "Hematopoietic malignancy, NOS",
                    "HEMOLYMPHORETICULAR TUMOR, MALIGNANT",
                    "Hematopoietic and Lymphoid Neoplasm",
                    "Hematopoietic Neoplasms Including Lymphomas",
                    "Hematologic Malignancy",
                    "Malignant Hematopoietic Neoplasm",
                    "Hematologic Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C27134",
                "name": "Hematopoietic and Lymphoid Cell Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C35813",
                    "C26323",
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Malignant Solid Neoplasm",
                    "Metastatic Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Neoplasm",
                    "Solid Tumour",
                    "Solid tumor, NOS"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Blood Disorder",
                    "Hematologic Disorder",
                    "Hematological Disorder",
                    "Blood Disease"
                ],
                "nci_thesaurus_concept_id": "C26323",
                "name": "Hematologic and Lymphocytic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C35814"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hematopoietic and Lymphoid System Tumor"
                ],
                "nci_thesaurus_concept_id": "C35813",
                "name": "Hematopoietic and Lymphoid System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C35814",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hematopoietic and Lymphoid System Disease"
                ],
                "nci_thesaurus_concept_id": "C35814",
                "name": "Hematopoietic and Lymphoid System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "ARC-12",
        "active_sites_count": 9,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Drugs",
                            "Antiproliferative Agents",
                            "Antineoplastics",
                            "Cancer Drug",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Drugs",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C159549",
                        "name": "Zimberelimab",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Anticancer Antibody",
                            "Antineoplastic Ab"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Biological Response Modifier",
                            "Immune Modulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biomodulators",
                            "Immune Mediators",
                            "BRM",
                            "Immunomodulatory Agent",
                            "Immunomodulating Agent",
                            "Immunomodulators",
                            "Immunopotentiators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-TIGIT MoAb",
                            "Anti-immunoglobulin (Ig) and Immunoreceptor Tyrosine-based iInhibitory Motif Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C134787",
                        "name": "Anti-TIGIT Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C20401",
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Anticancer Antibody",
                            "Antineoplastic Ab"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological",
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Biological Response Modifier",
                            "Immune Modulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biomodulators",
                            "Immune Mediators",
                            "BRM",
                            "Immunomodulatory Agent",
                            "Immunomodulating Agent",
                            "Immunomodulators",
                            "Immunopotentiators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Protein PD-1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "PD-1-targeting Agent",
                            "PD-1 Inhibitor",
                            "Programmed Cell Death Protein 1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmacological Substance",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Biological Products",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Immunologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C179552",
                        "name": "Ralzapastotug",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C134787",
                            "C129822"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmacological Substance",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological",
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Biological Products",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Immunologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Drugs",
                            "Antiproliferative Agents",
                            "Antineoplastics",
                            "Cancer Drug",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Drugs",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Dose Escalation Q3W Cohorts",
                "description": "Escalating doses of AB308 in combination with zimberelimab (360 mg) will be given every 3 weeks in participants with advanced malignancies.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Escalation Q4W Cohorts",
                "description": "Escalating doses of AB308 in combination with zimberelimab (480 mg) will be given every 4 weeks in participants with advanced malignancies.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Escalation Q6W Cohort",
                "description": "Selected dose of AB308 in combination with zimberelimab will be given every 6 weeks in participants with advanced malignancies.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Expansion Cohort 1",
                "description": "AB308 will be given in combination with zimberelimab at 360 mg or 480 mg Q3W or Q4W, respectively, in participants with in participants with locally advanced or metastatic NSCLC.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Expansion Cohort 2",
                "description": "AB308 will be given in combination with zimberelimab at 360 mg or 480 mg Q3W or Q4W, respectively, in participants with melanoma.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Expansion Cohort 3",
                "description": "AB308 will be given in combination with zimberelimab at 360 mg or 480 mg Q3W or Q4W, respectively, in participants with metastatic gastric, or gastroesophageal junction, or esophageal cancer.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Expansion Cohort 4",
                "description": "AB308 will be given in combination with zimberelimab at 360 mg or 480 mg Q3W or Q4W, respectively, in participants with cervical cancer.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Expansion Cohort 5",
                "description": "AB308 will be given in combination with zimberelimab at 360 mg or 480 mg Q3W or Q4W, respectively, in participants with hematological malignancies.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2021-05683",
        "why_study_stopped": null,
        "brief_summary": "This is a Phase 1/1b, multicenter, open-label, dose-escalation, and dose-expansion study to\r\n      evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and clinical\r\n      activity of AB308 in combination with zimberelimab (AB122) in participants with advanced\r\n      malignancies.",
        "brief_title": "A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies",
        "status_history": [
            {
                "status_date": "2021-03-19T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 107,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 0,
        "start_date": "2021-03-19",
        "record_verification_date": "2023-02-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": "ARC-12",
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-12-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]